Guo‐Feng Luo
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoplatforms for cancer theranostics 36
-
- Advanced biosensing and bioanalysis techniques 23
- RNA Interference and Gene Delivery 14
- Co-authors
- Xian‐Zheng Zhang (49 shared papers)Wei‐Hai Chen (40 shared papers)Ren‐Xi Zhuo (17 shared papers)Qi Lei (19 shared papers)Si‐Xue Cheng (12 shared papers)Wen‐Xiu Qiu (11 shared papers)Sheng Hong (8 shared papers)Huizhen Jia (12 shared papers)
In The Last Decade
Guo‐Feng Luo
70 papers receiving 4.5k citations
Guo‐Feng Luo's Hit Papers
Peers
Comparison fields: 5 of 130
- Biomaterials 1.9k
- Biomedical Engineering 2.7k
- Materials Chemistry 1.4k
- Surfaces, Coatings and Films 176
- Molecular Medicine 120
Countries citing papers authored by Guo‐Feng Luo
This map shows the geographic impact of Guo‐Feng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Feng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Feng Luo more than expected).
Fields of papers citing papers by Guo‐Feng Luo
This network shows the impact of papers produced by Guo‐Feng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Feng Luo. The network helps show where Guo‐Feng Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Guo‐Feng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multifunctional Envelope-Type Mesoporous Silica Nanoparticles for Tumor-Triggered Targeting Drug Delivery Hit paper breakdown → | 2013 | 474 |
| 2 | 2017 | 326 | |
| 3 | 2018 | 322 | |
| 4 | 2018 | 232 | |
| 5 | 2015 | 215 | |
| 6 | 2016 | 173 | |
| 7 | 2021 | 165 | |
| 8 | 2016 | 156 | |
| 9 | 2020 | 156 | |
| 10 | 2014 | 141 | |
| 11 | 2015 | 123 | |
| 12 | 2013 | 110 | |
| 13 | 2014 | 103 | |
| 14 | 2012 | 103 | |
| 15 | 2017 | 103 | |
| 16 | 2021 | 100 | |
| 17 | 2013 | 92 | |
| 18 | 2012 | 90 | |
| 19 | 2013 | 78 | |
| 20 | 2013 | 72 |
About Guo‐Feng Luo
Guo‐Feng Luo is a scholar working on Biomedical Engineering, Molecular Biology, Biomaterials, Materials Chemistry and Cancer Research, having authored 74 papers that have together received 4.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (36 papers), Nanoparticle-Based Drug Delivery (25 papers), Advanced biosensing and bioanalysis techniques (23 papers), RNA Interference and Gene Delivery (14 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer Research and Treatments (5 papers), Metal-Organic Frameworks: Synthesis and Applications (5 papers) and Advanced Nanomaterials in Catalysis (5 papers). The work is most often cited by research in Biomaterials (1.9k citations), Biomedical Engineering (2.7k citations), Materials Chemistry (1.4k citations), Surfaces, Coatings and Films (176 citations) and Molecular Medicine (120 citations). Guo‐Feng Luo has collaborated with scholars based in China, Israel and Maldives. Frequent co-authors include Xian‐Zheng Zhang, Wei‐Hai Chen, Ren‐Xi Zhuo, Qi Lei, Si‐Xue Cheng, Wen‐Xiu Qiu, Sheng Hong, Huizhen Jia, Li‐Han Liu and Xuan Zeng. Their work appears in journals such as Small, Nano Letters, Advanced Functional Materials, ACS Nano and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.